Kestra Medical Technologies Ltd. (KMTS) Stock Forecast & Price Target

Compare

7 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

KMTS Analyst Ratings

Strong Buy

5 Buy

1 Hold

0 Sell

Based on 6 analysts giving stock ratings to

Kestra

Medical Technologies Ltd.

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

KMTS Stock 12 Month Forecast

Average Price Target

$27.67

▲(13.96%Upside)

Based on 6 Wall Street analysts offering 12 month price targets for Kestra Medical Technologies Ltd. in the last 3 months. The average price target is $27.67 with a high forecast of $30.00 and a low forecast of $24.00. The average price target represents a 13.96% change from the last price of $24.28.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"19":"$19","22":"$22","25":"$25","28":"$28","31":"$31"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":30,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$30.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":27.67,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$27.67</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":24,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$24.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[19,22,25,28,31],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2024","6":"Dec<br/>2024","9":"Mar<br/>2025","12":"May<br/>2025","25":"May<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,22.96,23.501538461538463,24.043076923076924,24.584615384615386,25.126153846153848,25.66769230769231,26.20923076923077,26.75076923076923,27.292307692307695,27.833846153846153,28.37538461538462,28.916923076923077,29.45846153846154,{"y":30,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,22.96,23.322307692307692,23.684615384615384,24.04692307692308,24.40923076923077,24.771538461538462,25.133846153846154,25.49615384615385,25.85846153846154,26.220769230769232,26.583076923076923,26.94538461538462,27.30769230769231,{"y":27.67,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,22.96,23.04,23.12,23.2,23.28,23.36,23.44,23.52,23.6,23.68,23.76,23.84,23.92,{"y":24,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":20.99,"date":1717200000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":20.99,"date":1719792000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":20.99,"date":1722470400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":20.99,"date":1725148800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":20.99,"date":1727740800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":20.99,"date":1730419200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":20.99,"date":1733011200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":20.99,"date":1735689600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":20.99,"date":1738368000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":20.99,"date":1740787200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":20.99,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":24.58,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.96,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$30.00

Average Price Target$27.67

Lowest Price Target$24.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

TipRanks AITipRanks

Not Ranked

TipRanks

$22.5

Sell

-7.33%

Downside

Reiterated

05/18/25

Kestra Medical Technologies Ltd.'s stock score is primarily impacted by its strong revenue growth, but this is overshadowed by significant financial challenges, including negative equity and ongoing cash flow issues. Technical analysis provides a slight positive note with short-term momentum, but valuation concerns due to a negative P/E ratio weigh heavily. The absence of earnings call data and significant corporate events means these factors do not influence the score.

Travis SteedBank of America Securities

Bank of America Securities

$30

Buy

23.56%

Upside

Reiterated

04/14/25

Kestra Medical Technologies Ltd.: Positioned for Growth with Strong Financials and Innovative Market Strategy

Larry BiegelsenWells Fargo

Wells Fargo

$28

Buy

15.32%

Upside

Initiated

03/31/25

Kestra Medical initiated with an Overweight at Wells FargoKestra Medical initiated with an Overweight at Wells Fargo

Michael PolarkWolfe Research

Wolfe Research

$29

Buy

19.44%

Upside

Initiated

03/31/25

Kestra Medical Technologies: Positioned for Growth in the Wearable Cardioverter Defibrillator Market

Rick WiseStifel Nicolaus

Stifel Nicolaus

$28

Buy

15.32%

Upside

Initiated

03/31/25

Buy Rating for Kestra Medical Technologies Ltd. Driven by Strong Growth Prospects and Strategic Market Positioning

David RomanGoldman Sachs

Goldman Sachs

$24

Hold

-1.15%

Downside

Initiated

03/31/25

Kestra Medical Technologies: Strong Growth Potential Balanced by Current Valuation in MedTech Sector

Matthew O'BrienPiper Sandler

Piper Sandler

$27

Buy

11.20%

Upside

Initiated

03/31/25

Kestra Medical Technologies: Positioned for Growth with Next-Gen Wearable Cardioverter Defibrillator

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

TipRanks AITipRanks

Not Ranked

TipRanks

$22.5

Sell

-7.33%

Downside

Reiterated

05/18/25

Travis SteedBank of America Securities

Bank of America Securities

$30

Buy

23.56%

Upside

Reiterated

04/14/25

Kestra Medical Technologies Ltd.: Positioned for Growth with Strong Financials and Innovative Market Strategy

Larry BiegelsenWells Fargo

Wells Fargo

$28

Buy

15.32%

Upside

Initiated

03/31/25

Kestra Medical initiated with an Overweight at Wells FargoKestra Medical initiated with an Overweight at Wells Fargo

Michael PolarkWolfe Research

Wolfe Research

$29

Buy

19.44%

Upside

Initiated

03/31/25

Kestra Medical Technologies: Positioned for Growth in the Wearable Cardioverter Defibrillator Market

Rick WiseStifel Nicolaus

Stifel Nicolaus

$28

Buy

15.32%

Upside

Initiated

03/31/25

Buy Rating for Kestra Medical Technologies Ltd. Driven by Strong Growth Prospects and Strategic Market Positioning

David RomanGoldman Sachs

Goldman Sachs

$24

Hold

-1.15%

Downside

Initiated

03/31/25

Kestra Medical Technologies: Strong Growth Potential Balanced by Current Valuation in MedTech Sector

Matthew O'BrienPiper Sandler

Piper Sandler

$27

Buy

11.20%

Upside

Initiated

03/31/25

Kestra Medical Technologies: Positioned for Growth with Next-Gen Wearable Cardioverter Defibrillator

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Kestra Medical Technologies Ltd.

1 Month

xxx

Success Rate

0/2 ratings generated profit

Average Return

-2.45%

reiterated a xxx

rating 2 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 0.00% of your transactions generating a profit, with an average return of -2.45% per trade.

3 Months

xxx

Success Rate

0/2 ratings generated profit

Average Return

-25.80%

reiterated a xxx

rating 19 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of -25.80% per trade.

1 Year

Larry BiegelsenWells Fargo

Success Rate

0/2 ratings generated profit

Average Return

-25.80%

reiterated a buy rating 19 days ago

Copying Larry Biegelsen's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -25.80% per trade.

2 Years

xxx

Success Rate

0/2 ratings generated profit

Average Return

-25.80%

reiterated a xxx

rating 19 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -25.80% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

KMTS Analyst Recommendation Trends

Rating

Mar 25

Apr 25

May 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, KMTS has received 9 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. KMTS average Analyst price target in the past 3 months is 27.67.

Each month's total comprises the sum of three months' worth of ratings.

KMTS Financial Forecast

KMTS Earnings Forecast

Next quarter’s earnings estimate for KMTS is -$0.60 with a range of -$0.62 to -$0.59. The previous quarter’s EPS was -$1.25. KMTS beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 38.89% of the time in the same period. In the last calendar year KMTS has Preformed in-line its overall industry.

KMTS Sales Forecast

Next quarter’s sales forecast for KMTS is $15.07M with a range of $15.00M to $15.09M. The previous quarter’s sales results were $15.09M. KMTS beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 47.56% of the time in the same period. In the last calendar year KMTS has Outperformed its overall industry.

KMTS Stock Forecast FAQ

What is KMTS’s average 12-month price target, according to analysts?

Based on analyst ratings, Kestra Medical Technologies Ltd.’s 12-month average price target is 27.67.

What is KMTS’s upside potential, based on the analysts’ average price target?

Kestra Medical Technologies Ltd. has 13.96% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is KMTS a Buy, Sell or Hold?

Kestra Medical Technologies Ltd. has a consensus rating of Strong Buy which is based on 5 buy ratings, 1 hold ratings and 0 sell ratings.

What is Kestra Medical Technologies Ltd.’s price target?

The average price target for Kestra Medical Technologies Ltd. is 27.67. This is based on 6 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $30.00 ,the lowest forecast is $24.00. The average price target represents 13.96% Increase from the current price of $24.28.

What do analysts say about Kestra Medical Technologies Ltd.?

Kestra Medical Technologies Ltd.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 6 Wall Streets Analysts.

How can I buy shares of KMTS?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Kestra Medical Technologies Ltd. (KMTS) Stock Forecast & Price Target

KMTS Analyst Ratings

KMTS Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Kestra Medical Technologies Ltd.

KMTS Analyst Recommendation Trends

KMTS Financial Forecast

KMTS Earnings Forecast

KMTS Sales Forecast

KMTS Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts